Nucleic acid vaccines for prevention of flavivirus infection

Details for Australian Patent Application No. 2002307147 (hide)

Owner The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services, Centers for Disease Control and Prevention

Inventors Chang, Gwong-Jen J.

Agent Pizzeys

Pub. Number AU-B-2002307147

PCT Number PCT/US02/10764

PCT Pub. Number WO2002/081754

Priority 09/826,115 04.04.01 US

Filing date 4 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 22 February 2007

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 09/826,115 04.04.01 US

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002307147

22 February 2007 Application Accepted

  Published as AU-B-2002307147

21 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002307148-AUTOANTIBODIES TO GLUCOSE6-PHOSPHATE ISOMERASE AND THEIR PARTICIPATION IN AUTOIMMUNE DISEASE

2002307146-AlphaNuBeta3 integrin-binding polypeptide monobodies and their use